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A B S T R A C TObjectives: A set of indicators to assess the quality of a childhood
cancer system has not been identiﬁed in any jurisdiction internation-
ally, despite the movement toward increased accountability and
provision of high-quality care with limited health care resources. This
study was conducted to develop a set of quality indicators (QIs) of a
childhood cancer control and health care delivery system in Ontario,
Canada. Methods: A systematic review and targeted gray literature
search were conducted to identify potential childhood cancer QIs. A
series of investigator focus group sessions followed to review all QIs
identiﬁed in the literature, and to generate a provisional QI set for a
childhood cancer system. QIs were evaluated by three content experts
in a sequential selection process on the basis of a series of criteria to
select a subset for presentation to stakeholders. Following an
appraisal of the relevance of quality assessment frameworks, remain-
ing QIs were mapped onto the Cancer System Quality Indexsee front matter Copyright & 2013, International S
r Inc.
1016/j.jval.2013.03.1627
erg@pogo.ca.
ndence to: Mark L. Greenberg, Pediatric Oncology Gframework. Results: The systematic review yielded few relevant
childhood cancer system QIs. Overall, 120 provisional QIs were
developed by the investigator group. Based on median QI rating
scores, representation across the childhood cancer continuum, and
feasibility of data collection, a subset of 33 QIs was selected for
stakeholder consideration. Conclusions: The subset of 33 QIs devel-
oped on the basis of a systematic literature review and consensus
provides the basis for the selection of a set of QIs for ongoing,
standardized monitoring of various dimensions of quality in a child-
hood cancer system.
Keywords: health care, neoplasm, pediatric, quality appraisal, quality
improvement, quality indicators, quality of care.
Copyright & 2013, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Cancer remains the most common disease-related cause of death
among children in North America [1–4], despite signiﬁcant
improvements in survival rates over the past 20 years [3,4]. Care
for children with cancer is complex, due to the severity and high
acuity of illness, intensity of care, and immediate and long-term
consequences of treatment. Despite the existence of a set of
quality indicators (QIs) of the cancer control system for adults in
Ontario, Canada [5,6], and an increasing international interest in
assessing the quality of pediatric cancer care using QIs [7], a set of
indicators to assess the quality of a childhood cancer system has
not been identiﬁed in any jurisdiction in Canada or internation-
ally against which the overall system performance can be
compared by using benchmarks.
A QI is deﬁned as “a measurable element of practice perform-
ance for which there is evidence or consensus that it can be used
to assess the quality, and hence change in the quality, of care
provided” [8]. QIs are being increasingly used to measure and
improve the quality of health care and enable evidence-basedplanning, management, and policy development [5,6,9]. The
evaluation of outcomes, ability to measure key quality dimen-
sions of the childhood cancer system, identiﬁcation of potential
gaps, and establishment of benchmarks for the practice of
pediatric oncology are incrementally important domains of
health care system evaluation and accountability in an era of
providing high-quality care with limited health care resources in
a publicly funded health care system.
The provincial coordination of childhood cancer services in
Ontario, Canada, has been achieved through the Pediatric Oncol-
ogy Group of Ontario (POGO), a collaboration of ﬁve specialty
pediatric cancer programs within academic tertiary hospitals in
Ontario and the community hospitals and cancer centers that
deliver POGO provincial pediatric oncology programs. POGO
identiﬁes areas for cancer system development for the provincial
Ministry of Health and Long-Term Care and operates in ongoing
collaboration with families of children with cancer, survivors,
corporate and private benefactors, and volunteers. As part of its
mandate for advancing and monitoring the childhood cancer
system, POGO has, since 1985, actively and prospectivelyociety for Pharmacoeconomics and Outcomes Research (ISPOR).
roup of Ontario, 480 University Avenue, Suite 1014, Toronto, ON,
Table 1 – Sixteen common quality concept areas of
health, education, and social service system quality
assessment frameworks [12].
Quality concept
area
Deﬁnition
Access and
Availability
 Extent to which services are available
and accessible (geographic location,
physical environment, affordability) in a
timely manner.
Coordination and
Collaboration
 Coordination: Provision of services that
are continuous, integrated, and organized
around the patient, both within and
across service settings and over time.
 Collaboration: Linkages and partnerships
V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) 6 4 7 – 6 5 4648collected standardized, population-based sociodemographic,
diagnostic, therapeutic, and outcome data on each new case of
childhood cancer diagnosed and treated in Ontario through its
Networked Information System (POGONIS) [10]. POGO also over-
sees and funds the delivery of provincial pediatric oncology
programs, including a pediatric oncology Satellite system of
devolved care, operating at seven community-based hospitals;
AfterCare—long term follow-up clinics for pediatric and adult
survivors of childhood cancer; and Interlink—a nursing program
that facilitates access to care and support services for children
and their families at all stages of illness—in the hospital,
community, and at home.
The aim of this study was to develop a quality assessment
framework with a set of well-deﬁned, evidence-based, and
expert-informed QIs for the pediatric cancer system in Ontario,
to be assessed by a multidisciplinary Delphi panel representing
the broader provincial pediatric cancer stakeholder community.that are established among different
service delivery systems, networks, and
providers to enable effective planning
and the implementation of a high-
quality integrated service.
Equity and Fairness  Provision of services that are of equal
quality and that are distributed fairly
across populations, regardless of patient
characteristics (e.g., sex, ethnicity,
impairment, geographic location, and
socioeconomic status).
Family-Centered†  Extent to which the planning and delivery
of services involves families, provides
them with information to support their
decision making, and is positive,
acceptable, and responsive to their needs
and expectations, and respectful of
privacy, conﬁdentiality, and differences
(e.g., cultural, socioeconomic).
Patient Safety  Any actual or potential harm to the
patient, through the provision of a
service, that is prevented, avoided,
reduced, or minimized through
integrated risk management activities.
Appropriateness  Provision of services that are based on
established standards and evidence and
relevant to patient needs.
Comprehensiveness  Extent to which there is a range of
services provided that is broad enough in
scope and depth to meet patient needs.
Workforce
Development
 Degree to which a service delivery
system manages and develops its
workforce through a variety of processes
(e.g., provision of a supportive and safe
work environment, providing
opportunities for learning and growth,
and valuing staff satisfaction).
Quality
Improvement
Processes
 System of processes and activities that
promotes continuous quality improve-
ment, including those related to program
evaluation, performance monitoring,
accountability, and accreditation.Methods
The development of a quality measurement set involved three
phases: 1) review of quality assessment frameworks, 2) QI devel-
opment and framework selection, and 3) assessing stakeholder
agreement (modiﬁed Delphi process). We describe the ﬁrst two
phases in this article and phase three in a companion article [11].
Phase I: Review of Quality Assessment Frameworks
A recent, comprehensive systematic review of quality assess-
ment frameworks in the health, education, and social service
sectors [12] was explored to assess the suitability of existing
frameworks for a childhood cancer system. A total of 111 quality
assessment frameworks were identiﬁed, none of which were
speciﬁc to childhood cancer [12]. Based on a concept sorting
exercise of 1488 quality domains, a set of 16 common quality
concept areas was identiﬁed in the review (Table 1) [12] and used
in this study to generate a provisional QI set.
Phase II: QI Development and Framework Selection
Systematic review of existing QIs
Medline and Embase databases were searched for studies pub-
lished between January 1, 1996, and April 30, 2010 (see Appendix A
in Supplemental Materials found at http://dx.doi.org/10.1016/j.jval.
2013.03.1627). English-language studies were included if one or
more QIs for a pediatric cancer system were addressed. Studies
were excluded if not available in full text, as were comments,
editorials, letters, or conference papers/ proceedings.
Citations were screened on the basis of title and abstract
review for potential relevance to quality of care, quality improve-
ment, quality assurance, benchmarks, standards of care, per-
formance measures, or performance indicators and pediatric
oncology. Citations that were related to both quality and child-
hood cancer were screened in full text by two reviewers, and all
other citations were excluded.
A targeted scan of the gray literature (search strategy available
from the authors upon request) was conducted in January 2009
(updated in April 2010) of 58 organizational and governmental
Websites, including the Agency for Healthcare Research and
Quality, and electronic databases of evidence-based quality
measures [13] and guidelines [14] to identify existing pediatric
cancer QIs. Generic adult cancer QIs in broadly applicable areas,
such as symptom management, pathology reporting, and end-of-
life care, were also searched from a number of measurement sets
[6,15–17]. QIs were considered eligible for inclusion if they were
pediatric cancer–speciﬁc QIs or concept areas. Those from the
Table 1 – continued
Quality concept
area
Deﬁnition
Creating and Using
Knowledge
 Extent of commitment to a continuous
learning environment that supports
research, the development,
dissemination, and exchange of
information and knowledge, and the
creation and application of evidence-
based practice guidelines and standards.
Effectiveness  Extent to which a service achieves the
desired result, assessed largely with
reference to outcomes, which may be at
the individual patient or broader
population level.
Patient/Family
Perspective‡
 Extent to which the patient/family
perspective and experience of a service
is measured and valued as an outcome
of service delivery.
Leadership/
Governance
 How a service or organization engages in
strategic planning processes to develop
and facilitate the achievement of its
values, mission, and vision, to be
responsive to change, and to achieve
sustainable success.
Infrastructural
Capacity
 A service or organization infrastructure,
e.g., physical facilities, equipment, ﬁscal
resources, human resources, and
information technology.
Financial
Management
 Extent to which business and ﬁnancial
management plans are developed,
implemented, and monitored, and
address issues such as efﬁciency,
resource allocation, stability, and
process management.
The original domains of “Collaboration” and “Coordination” were
merged as “Collaboration and Coordination” because of overlap
in quality indicators.
†The “Family-Centered” domain was adapted from “Client-Cente-
redness” in the original quality concept groups.
‡The “Patient/Family Perspective” domain was adapted from
“Client perspective” in the original quality concept grouping.
V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) 6 4 7 – 6 5 4 649gray literature were reviewed by two investigators to remove any
duplicates.Development of a provisional QI set
A series of investigator focus group sessions was held over 18
months to review all QIs identiﬁed from the literature and to
generate a provisional QI set. The investigator group consisted of
high-level decision makers from POGO, experienced pediatric can-
cer content expert clinicians, and methodologists in epidemiology,
health services research, guidelines development, and performance
measurement. The initial intent was to encompass the 16 common
quality concept areas [12], which were used to brainstorm potential
QIs of Ontario’s childhood cancer system.Key considerations for the QI development were that indica-
tors had to be comprehensive and span the childhood cancer care
trajectory; have the potential to enhance or afﬁrm the quality and
level of functioning of the system; and have feasible data
collection, including the identiﬁcation of a probable source and
the ability to retrieve and collect standardized data. The avail-
ability of known benchmarks and time frame for yielding new or
actionable information were also considered. Provisional QIs
were identiﬁed as being speciﬁc to Ontario or applicable to other
jurisdictions and deﬁnitions were drafted.
Evaluation and selection of a subset of QIs
The provisional QIs were evaluated by three content experts to
select a priority subset for presentation to stakeholders by using a
modiﬁed Delphi panel process (described elsewhere) [11]. First,
the experts undertook a “quick screen” review of each QI
independently. QIs had to fulﬁll all four criteria of the quick
screen phase, which assessed QIs on a categorical scale (“yes” or
“no”) (Table 2). A second, independent scoring used seven
selection criteria (Table 2) and a four-point Likert scale (where
“1” ¼ “strongly disagree” and “4” ¼ “strongly agree”). This was
completed for each QI that fulﬁlled all four quick screen criteria.
An overall Likert score (maximum of 28) was calculated for
each QI.
Further QI deﬁnition and speciﬁcation
The priority QI subset was further reﬁned to obtain a stand-
ardized measure with explicit predeﬁned requirements for data
collection and calculation of the measured value, including
numerator/denominator speciﬁcation, QI rationale, and source
of data, risk adjustment or stratiﬁcation, sampling time frame,
and directionality and interpretation of the score.
Selection of a quality assessment framework for Ontario’s
Childhood Cancer System
Although the 16 common quality concept areas [12] were useful
for generating a comprehensive provisional QI list, other quality
assessment frameworks were reassessed for applicability to
Ontario’s childhood cancer system to select a feasible and under-
standable reporting structure.Results
Phase I: Review of Quality Assessment Frameworks
None of the frameworks evaluated [12,18–20] were initially
considered appropriate for assessing the quality of Ontario’s
childhood cancer system. The 16 common quality concept areas
[12], however, were held to provide the most comprehensive
basis for generating QIs of this system.
Phase II: QI Development and Framework Selection
Systematic review of existing QIs
The Medline and Embase search yielded 845 unique citations, of
which 4 met the inclusion criteria [21–24] (Fig. 1) and are
summarized in Table 3. None of the indicators proposed in these
studies were adopted directly in the provisional QI set.
The National Institute for Health and Clinical Excellence’s
2005 Improving Outcomes in Cancer series [25,26] was the only
source identiﬁed in the targeted gray literature search speciﬁc to
childhood cancer. Its purpose was to give recommendations on
service provision for children and young people with cancer
based on the best available evidence, with links to 177 measure-
ment suggestions ranging across 13 thematic concept areas
Table 2 – Provisional quality indicator selection
criteria.
Selection criteria Description
Quick screen criteria
1. Overall importance The QI measures an important
health issue or aspect of the
functioning of the childhood
cancer system.
2. Relevance This QI is relevant to capturing
quality at the level of the
system.
3. Alignment with childhood
cancer mission statement
This QI aligns with the broadly
applicable POGO childhood
cancer mission statement.
4. Alignment with strategic
objectives of the childhood
cancer system
This QI aligns with at least one
of eight broadly applicable
POGO strategic objectives of
the childhood cancer system.
Primary selection criteria
1. Scientiﬁc soundness and
face validity
This QI makes sense and
measures what is intended
and is reasonable to the
larger community (face
validity).
2. Relevance to quality
improvement
This QI will drive quality
improvement in childhood
cancer care.
3. Relevance to health care
accountability
This QI will increase health
care accountability in
childhood cancer.
4. Relevance to the
identiﬁcation of important
system gaps
This QI will detect important
gaps in childhood cancer
care.
5. Directionality and
interpretability
This QI demonstrates clear
directionality and is
interpretable, where changes
in the indicator are
commonly understood to be
beneﬁcial or negative.
6. Addresses a priority area This QI measures a high-
volume, high-risk, or high-
needs issue in pediatric
oncology.
7. Target audience This QI will be meaningful and
of interest to at least one
target stakeholder group,
including decision makers
(e.g., MOHLTC and LHIN);
hospitals (e.g., health care
providers and hospital
administrators); or families,
parents, and/or survivors of
childhood cancer.
LHIN, Local Health Integration Network; MOHLTC, Ministry of
Health and Long-Term Care; POGO, Pediatric Oncology Group of
Ontario; QI, quality indicator.
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concept constructs and not measurable QIs [25,26]. A number of
the concept constructs were helpful in generating QIs (e.g.,
“number of pediatric intensive care admissions as a result of
neutropenic sepsis,” “complication rates, particularly incidence
of central venous line-associated infection”) [25,26]. Some were
not applicable to the Canadian context (e.g., “demonstration ofadherence to the requirements of the European Union Directive
on Good Clinical Practice”), while others were considered too
microfocused (e.g., “access for patients who require dental
follow-up posttreatment”), or were better suited for a research
study (e.g., “effect of bereavement advice on quality of life of
parents/carers and siblings”) [25,26].
Development of a provisional QI set
A total of 120 provisional QIs were generated, spanning the
childhood cancer continuum and the 16 common quality concept
areas [12]. Details of the 120 provisional QIs are available from the
authors upon request. The most frequently measured quality
concept area was Access and Availability, which encompassed 52
provisional QIs (43%).
Evaluation and selection of a subset of QIs
Based on the initial evaluation of provisional QIs, 89 (74%) met all
four quick screen selection criteria (Fig. 2). These 89 QIs were
scored highly, with 91% scored in the top quartile (median overall
Likert score range of 14–28). Based on median overall Likert
scores, representation across the childhood cancer care trajec-
tory, and feasibility of data collection and implementation, a
subset of 33 QIs was selected for presentation to stakeholders
(Fig. 2). The majority were process indicators (70%), while six
(18%) were structural indicators and four (12%) were outcome
indicators. Some QIs were deemed better examined in research
studies and excluded (e.g., health-related quality of life, cost-
analysis of fever/neutropenia treatment in ambulatory vs. inpa-
tient setting). Other QIs were excluded because of the lack of
evidence for or consensus on a standard (e.g., acceptable wait
time or delay in access to social work or neuropsychology).
Further QI deﬁnition and speciﬁcation
Appendix B in Supplemental Materials found at http://dx.doi.org/
10.1016/j.jval.2013.03.1627 presents the subset of 33 proposed QIs,
including the deﬁnition, source of data, rationale, and other
technical speciﬁcations for the calculation of a measured value.
Selection of a quality assessment framework for Ontario’s
Childhood Cancer System
This QI subset was mapped onto the Cancer System Quality
Index (CSQI) [18], which was considered to best reﬂect the key
quality dimensions of the childhood cancer system and addition-
ally, allow for comparability between provincial pediatric and
adult cancer systems. The CSQI was developed by Cancer Care
Ontario and the Cancer Quality Council of Ontario to monitor and
report on Ontario’s adult cancer system performance and
includes seven quality dimensions [18], deﬁned in Table 4. After
the mapping exercise, all seven CSQI dimensions contained at
least one proposed QI of the childhood cancer system (Table 5).Discussion
This study describes a process used to deﬁne and select a set of
evidence- and consensus-based QIs for a childhood cancer sys-
tem, leading to a prioritized subset of 33 QIs to be presented to
stakeholders. The process used a systematic review, analysis of
evidence, deﬁnition of key constructs of system quality and
measurement speciﬁcations, and an iterative process for generat-
ing consensus. These 33 QIs span the childhood cancer contin-
uum of care, from diagnosis and treatment to survivorship, and
end-of-life care, and are quality measures of all seven dimensions
of the CSQI. The set of 33 QIs is intended to reﬂect the perspec-
tives of key stakeholder groups, including health care
providers, survivors, families, policymakers, and decision makers.
Citations related to Quality of Pediatric 
Cancer Care
(n = 33)
Excluded at Title and Abstract Screening:
Not related to Pediatric Cancer
(n = 122)
Citations related to Quality of Care
(n = 155)
Total Number of Citations
(n = 845)
Excluded at Title and Abstract Screening:
Not related to Quality of Care
(n = 690)
Full-Text Screening
(n = 12)
Excluded at Title and Abstract Screening:
Not on topic of Quality Measures/ Indicators 
(n = 21)
Total of 4 Included Studies
Excluded at Full-Text Review:
No Proposed Quality Indicators 
(n = 8)
Fig. 1 – Search results.
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to be examined for various levels of care, including community-
based and tertiary care, as well as for selected high-risk sub-
populations, such as adolescents with cancer. Although the
proposed QIs are focused on system quality in childhood cancer,
both the processes used in deﬁning and selecting a set of
evidence- and consensus-based QIs within a quality assessment
framework and some of the QIs, such as “Actual and Potential
Drug and Dose Errors,” may be applicable to a broader range of
pediatric disciplines and clinical practice and policy areas.
The QIs were evaluated on several selection criteria, including
overall importance, relevance, alignment with a childhood can-
cer mission statement and strategic objectives, scientiﬁc sound-
ness, interpretability, target audience, and priority area
addressed. While the face validity of the provisional QIs was
evaluated directly by content expert scoring, the content validity
was also a key consideration of scientiﬁc soundness for a QI,
which should accurately reﬂect the variable it has been intended
to measure. While feasibility of data collection was considered in
the development phase, it was used as a secondary selection
criterion to capture highly important, relevant, and meaningful
QIs for which data collection practices may not be established.
Thus, in some instances, the data source was not limited to that
currently collected in POGONIS, other existing registries, or
administrative databases.
The proposed QI set includes measures of three fundamental
dimensions of the care delivery system—structure, process, and
outcome measures. Although outcome measures may not be
measures only of system quality, these are appropriate for
instances in which health care services have large effects on
outcomes and data can be interpreted reliably, such as throughrisk adjustment [27]. Furthermore, changes in survival rates are
often used to evaluate the quality of care for cancer patients
across different periods of time and jurisdictions [28].
To date, no existing QI set has been developed for a childhood
cancer system in any jurisdiction. For most areas of health
services, quality-of-care assessment is evidence-based, yet lim-
ited evidence exists for quality measurement in pediatric oncol-
ogy [7]. Some provisional QIs were excluded during the QI review
phase because of challenges in the deﬁnition of a measurement
that accurately reﬂects the content area being examined (content
validity) and feasibility of data collection. Our set of prioritized
QIs, however, has been deﬁned with requirements for data
collection and for the calculation of a standardized value, based
on the best available evidence and expert consensus.
The majority of the 33 proposed QIs represent areas of system
quality that could be applied to other jurisdictions. The proposed
QI set, however, was developed to be applicable primarily to
Ontario’s comprehensive childhood cancer system, and there-
fore, the ﬁve QIs pertaining to devolved pediatric oncology treat-
ment, late effects surveillance, and a hospital, community, and
home-based pediatric oncology nursing program (identiﬁed in
Ontario as Satellite, AfterCare, and Interlink, respectively) may
not be generalizable to other jurisdictions that have not estab-
lished similar programs. Furthermore, although the construct of
access and availability to ambulatory pediatric oncology drugs
might be applicable to the quality of childhood cancer systems in
other jurisdictions, the drug availability QI measure is particular
to the Ontario Ministry of Health and Long-Term Care’s reim-
bursement process for speciﬁed drugs that require application
through the Exceptional Access Program. Therefore, other juris-
dictions should assess their local context to determine whether
First Evaluation of Provisional QIs based on Preliminary “Quick 
Screen” Selection Criteria
(n = 120 QIs)
Second Evaluation of Provisional QIs based on “Primary 
Selection Criteria”
(n = 89 QIs) 
Selection of QIs of the Childhood Cancer System 
for Stakeholder Consideration 
(n = 33 QIs)
Excluded after Quick Screen and 
Investigator Group Discussion*
(n = 31 QIs) 
Excluded after Indicator Scoring 
and Discussion 
(n = 56 QIs) 
Fig. 2 – Results of provisional quality indicator evaluation by content experts. QI, quality indicator. Thirty-one indicators were
excluded on the basis of the quick screen evaluation and discussion among the three content experts.
Table 3 – Summary of characteristics of included studies from systematic review.
Study Study objectives Proposed QIs
Applicability to the provisional
QI set
Dycus
et al.
[21]
To develop and test a Quality Improvement
Knowledge, Skills and Attitudes (QuISKA)
questionnaire to measure nursing quality
knowledge, skills, and attitudes of
practicing pediatric oncology nurses
 Nursing quality knowledge,
skills, and attitudes (measured
via the QuISKA questionnaire)
Better examined in a focused research
study and not as part of an ongoing
systems-level performance
measurement initiative
Pásztélyi
et al.
[22]
To report on “quality-of-care” indicators for
new cases of ﬁve common groups of
malignancies by the Hungarian Pediatric
Oncology Working Group
 Length of stay in hospital due to
treatment for initial disease;
 Diagnostic procedures,
complications, or days in
the ICU;
 Delays in treatment due to
technical reasons or due to
complications;
 Elapsed time from patient
admission until ﬁrst day of
chemotherapy.
Considered by investigator group; none
directly adopted in provisional QI set
Oakes
et al.
[23]
To describe the development and
implementation of an institutional
quality improvement initiative to
improve pain management for pediatric
cancer inpatients at St. Jude’s Children’s
Research Hospital in the United States
 Documentation of pain
intensity by using numeric
rating scales and
 Documentation of pain
intensity at frequent intervals
Patient-level symptom assessments
and were not considered to be
system-level QIs
Zernikow
et al.
[24]
National, longitudinal study (“STOP”) by the
German Society of Pediatric Haematology
and Oncology that aimed to
 improve pediatric oncology pain control in
Germany and
 evaluate the impact of the study on pain
management quality
 Number of pain assessments
per day and per patient;
 Mean daily pain rating;
 Percentage of daily pain rating
43 using a 1 to 6 smiley scale
(where 1 ¼ “no pain” and 6 ¼
“most pain”)
Patient-level symptom assessments
and were not considered to be
system-level QIs
ICU, intensive care unit; QI, Quality indicator.
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TABLE 4 – Seven quality dimensions of the Cancer System Quality Index (CSQI) [18].
Quality
dimension
Quality dimension deﬁnition
Safe Avoiding, preventing, and ameliorating adverse outcomes or injuries caused by health care management.
Effective Providing services based on scientiﬁc knowledge to all who could beneﬁt.
Responsive Providing care that is respectful of and responsive to individual patient preferences, needs, and values, and ensuring
that patient values guide all clinical decisions.
Integrated Coordinating health services across the various functions, activities, and operating units of a system.
Accessible Making health services available in the most suitable setting in a reasonable time and distance.
Equitable Providing care and ensuring health status does not vary in quality because of personal characteristics (sex, ethnicity,
geographic location, and socioeconomic status).
Efﬁcient Optimally using resources to achieve desired outcomes.
Table 5 – Proposed quality indicators of Ontario’s Childhood Cancer System (n ¼ 33), by Cancer System Quality
Index (CSQI) quality dimension.
Safety (n ¼ 6) Effectiveness (n ¼ 7)
 Chemotherapy certiﬁcation of nursing staff
 ICU Admissions due to neutropenic sepsis
 Potential drug/dose errors
 Actual drug/dose errors
 Central venous line infection rate
 Major clinical trial protocol violation
 Five-year overall relative survival
 Five-year event-free survival
 Treatment-related mortality
 Use of conformal or intensity-modulated RT
 Access to PET scanning
 Supportive care guidelines
 Guidelines for nutritional support
Integration (n ¼ 6) Responsiveness (n ¼ 1)
 Eligible patients enrolled in Satellite for chemotherapy
 Shuttle sheet
 Eligible survivors enrolled in AfterCare
 Survivors with a survivor care plan†
 Patients referred for end-of-life Interlink care
 Case coordinator
 Parent/guardian satisfaction
Accessibility (n ¼ 8) Equity (n ¼ 4) Efﬁciency (n ¼ 10)
 Clinical trial participation
 First therapeutic intervention wait time
 Chemotherapy admission delay
 After hours cancer surgery
 Wait time: Sedation for ambulatory procedures
 Adolescent cancer diagnosis in a pediatric center‡
 Sufﬁcient multidisciplinary staff
 Access to expert management of pain control
 Adolescent cancer
diagnosis in a
pediatric center‡
 Eligible patients
enrolled in Satellite
for chemotherapy
 Eligible survivors
enrolled in AfterCare
 Patients referred for
end-of-life Interlink
care
 Drug availability
 Time taken for the production of pathology reports
 Adolescent cancer diagnosis in a pediatric center‡
 Eligible patients enrolled in Satellite for chemotherapy
 Eligible survivors enrolled in AfterCare
 Survivors with a survivor care plan†
 Patients referred for end-of-life Interlink care
 End-of-life care days spent in acute care
 Interdisciplinary team meetings
 Tumor boards
ICU, intensive care unit; PET, positron emission tomography; RT, radiation therapy.
This indicator is assigned to the Integration, Equity, and Efﬁciency quality dimensions.
†This indicator is assigned to the Integration and Efﬁciency quality dimensions.
‡This indicator is assigned to the Accessibility, Equity, and Efﬁciency quality dimensions.
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to revise QIs or measure a subset of applicable QIs.
In the future, consideration may need to be given to additional
areas of a childhood cancer system, such as the quality of transition
of care for adolescents on active cancer treatment into adulthood,
or the quality of therapies offered when a cooperative group
clinical trial protocol is not available. Furthermore, QI sets should
be periodically reassessed and QIs potentially modiﬁed, removed, oradded to maintain relevance to the status of the current health care
system.Conclusions
The 33 QIs provide the basis for a set of indicators for ongoing,
standardized monitoring of various quality dimensions of a
V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) 6 4 7 – 6 5 4654childhood cancer system. The acceptability of these QIs among
key stakeholders of the system should be tested to determine
their validity, acceptability, importance, and meaningfulness.
Once implemented, these indicators can provide evidence based
on comparable and standardized measures of system quality that
can be used to stimulate and optimize accountability and con-
tinuous improvement within the health care system.Acknowledgments
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